Wayland, MA, United States of America

Hans Peter Ingemar Claesson

USPTO Granted Patents = 4 


Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 2011-2017

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Hans Peter Ingemar Claesson

Introduction

Hans Peter Ingemar Claesson is a prominent inventor based in Wayland, Massachusetts, recognized for his significant contributions to tissue engineering. With a total of four patents to his name, Claesson is making strides in the development of advanced biocompatible materials and innovative methodologies for medical applications, particularly in cartilage repair.

Latest Patents

Claesson's latest inventions include two groundbreaking patents focused on tissue implants. The first patent outlines a double-structured tissue implant designed for implantation into tissue defects. This implant consists of a primary scaffold made from collagen and a secondary scaffold that includes a soluble collagen solution combined with a surfactant. The preparation process involves lyophilization and dehydrothermal treatment, showcasing a blend of biochemistry and engineering.

The second patent introduces a cell-support matrix characterized by narrowly defined, uniformly vertically organized porosity and pore density. This innovative matrix is suitable for the preparation of cellular or acellular implants aimed at promoting the growth and de novo formation of articular hyaline-like cartilage. Additionally, the patent describes a gel-matrix composite system that induces hyaline-like cartilage production from chondrocytes both in vivo and in vitro, highlighting its potential in regenerative medicine.

Career Highlights

Hans Peter Ingemar Claesson is associated with Histogenics Corporation, a company known for its advancements in regenerative medicine. Throughout his career, Claesson has consistently focused on developing materials and technologies that enhance tissue repair and regeneration, bringing valuable innovation to the field.

Collaborations

In his pursuit of innovation, Claesson collaborates with notable coworkers Laurence J. B. Tarrant and Sonya Shortkroff. Their combined expertise fosters a productive environment aimed at transforming medical therapies and improving patient outcomes through tissue engineering.

Conclusion

Hans Peter Ingemar Claesson stands out as a leading figure in the realm of tissue engineering, with an impressive portfolio of patents that reflect his dedication to advancing medical science. His innovative work contributes to the ongoing evolution of treatment strategies aimed at repairing and regenerating damaged tissues. As he continues to push the boundaries of what is possible in this field, Claesson's contributions are sure to leave a lasting impact on the future of regenerative medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…